Syntax Bio Expands Series A Financing Round to $14.4 Million
Syntax Bio has expanded its Series A financing round to $14.4 million, bringing total funding raised by the synthetic biology company to over $25 million. The new capital will support further development in cell therapies and includes participation from existing investors.
Topics: biotech cell therapies synthetic biology venture capital